Castellanos Jorge M, Barbery Daniela, Yefimov Alex, Dang Phuong N
JMC Medical, Minimally Invasive Cardiac Care, Newport Beach, CA, USA.
Department of Cardiology, Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA.
Eur Heart J Case Rep. 2022 Oct 6;6(10):ytac384. doi: 10.1093/ehjcr/ytac384. eCollection 2022 Oct.
Virtual reality (VR) technology has been implemented as a pre-procedural planning tool for cardiovascular interventions to enable detailed evaluation of patient anatomy from different vantage points. Here, we employed a VR platform to preoperatively plan for percutaneous valve-in-valve transcatheter mitral replacement (ViV-TMVR) in a prohibitive surgical candidate.
An 85-year-old male with a history of two prior sternotomies for bioprosthetic aortic valve (AV) and mitral valve (MV) 31 mm Medtronic Mosaic bioprosthesis presented with severe mitral regurgitation from a degenerative bioprosthetic MV. The patient was deemed a prohibitive surgical candidate for a third sternotomy and instead was recommended a percutaneous transseptal ViV-TMVR. An electrocardiogram-gated chest computed tomography (CT) provided a neo-left-ventricular outflow tract (neo-LVOT) of 1.89 cm. This CT was reconstructed to create a 360° VR (360VR) model. A 29 mm SAPIEN three bioprosthetic valve, selected based on the already implanted MV, was placed inside the bioprosthetic MV and analysed in VR at different angles to ensure it would not obstruct the LVOT. The neo-LVOT measured in VR was 3.02 cm, which would allow for sufficient blood flow without significant obstruction from the new SAPIEN three bioprosthetic valve. The patient tolerated the procedure well.
This case demonstrates the utility of VR as a pre-procedural planning tool for interventional cardiology procedures. Preoperative planning in VR alleviated concerns regarding obstruction of the neo-LVOT and helped confirm safe implantation by clearly showing the three-dimensional spatial relationship between the implants and surrounding patient anatomy.
虚拟现实(VR)技术已被用作心血管介入手术的术前规划工具,以便从不同视角详细评估患者解剖结构。在此,我们使用一个VR平台,为一名手术高危的患者进行经皮瓣中瓣经导管二尖瓣置换术(ViV-TMVR)的术前规划。
一名85岁男性,有两次开胸置换生物瓣主动脉瓣(AV)和二尖瓣(MV)的病史,植入的是31mm美敦力Mosaic生物瓣,因生物瓣退变导致严重二尖瓣反流。该患者被认为是第三次开胸手术的高危候选人,因此建议行经皮经间隔ViV-TMVR。心电图门控胸部计算机断层扫描(CT)显示新左心室流出道(neo-LVOT)为1.89cm。对该CT进行重建以创建360°VR(360VR)模型。根据已植入的MV选择了一个29mm的SAPIEN 3生物瓣,将其置于生物瓣MV内,并在VR中从不同角度进行分析,以确保它不会阻塞LVOT。在VR中测量的neo-LVOT为3.02cm,这将允许足够的血流,且新的SAPIEN 3生物瓣不会造成明显阻塞。患者对手术耐受性良好。
本病例证明了VR作为介入心脏病学手术术前规划工具的实用性。VR术前规划减轻了对neo-LVOT阻塞的担忧,并通过清晰显示植入物与周围患者解剖结构之间的三维空间关系,有助于确认安全植入。